Chronic Kidney Disease Causes
Chronic Kidney Disease Causes
Chronic kidney disease is a description of function, and behind it sit several quite different mechanisms. This page takes the four that account for most cases and the ones that are worth excluding, then turns to the question patients actually control: what accelerates the loss of function once the disease is present, and what can be removed from the picture.
Diabetes: the commonest cause, and a slow one
Diabetic kidney disease develops over years of raised glucose, and it does so in a recognisable sequence. The first visible change is a leak: the filtering membrane becomes more permeable and albumin appears in the urine, at first in small amounts. The filtration rate often rises slightly before it falls. Then, over years, the filtering units scar, protein loss increases and the filtration rate declines.
Two features matter clinically. The first is that the early stage is entirely silent and entirely detectable — which is why annual urine testing exists and why it is worth insisting on. The second is that the process continues during the years before it is detectable, so a diagnosis made at the first abnormal urine test is already a diagnosis made early rather than at the beginning.
The reason this cause is worth naming precisely is that the treatment is not only about glucose. Several of the medicines used for diabetes also protect the kidney and the heart independently of the glucose they lower, and blood pressure control in diabetes is treated as seriously as glucose control. Where both are addressed, the slope changes substantially — which is the strongest argument for establishing the cause rather than only staging the disease.
High blood pressure: cause, consequence and accelerator
Hypertension and kidney disease are the clearest example in medicine of a condition that is simultaneously a cause, a result and a worsening factor. Sustained pressure damages the small vessels the filtering units depend on. Damaged kidneys handle salt and fluid less well and regulate pressure less well. The result is a loop in which each condition raises the other, and the loop is what makes untreated hypertension such a powerful driver of decline.
Which came first is often unanswerable after the fact, and — as with most things in this disease — it does not change what should be done. Pressure control is the single strongest lever on the rate of decline regardless of the original cause, and the medicines chosen for it are usually the ones that also lower pressure inside the filtering unit and reduce the protein leak.
The measurement itself deserves a word, because it is where outpatient care most often goes wrong. Blood pressure read in a clinic is a single moment in an anxious setting, and it misses both the night-time pattern and the white-coat effect. Home readings, taken seated after five minutes' rest and recorded over a week, describe what the kidney's vessels are actually being asked to withstand, and they are more useful than any single clinic number.
Glomerular and immune disease
This group is where the filtering unit itself is the target rather than a bystander, and it matters disproportionately because it is the group in which establishing the diagnosis most often changes the treatment. IgA nephropathy — in which an antibody deposits in the filter and provokes inflammation — is among the commonest primary glomerular diseases worldwide and often presents with visible blood in the urine during or just after an infection. Lupus nephritis is the kidney manifestation of a systemic autoimmune disease and is treated according to the tissue pattern found on biopsy. Others in the family present with heavy proteinuria and a faster tempo than diabetes or hypertension would explain.
The clinical signature that should raise suspicion is a combination rather than a single finding: blood and protein together in the urine, a decline that is faster than the underlying conditions explain, proteinuria that is heavy relative to the filtration rate, or onset in a younger person without diabetes. In those situations the decision about biopsy is genuinely open, because the result may shift treatment from supportive care to immune suppression.
These are also the causes most often handled in dedicated clusters elsewhere in this guide, because the management is specific enough to warrant its own pages — the point here is only that they belong in the differential rather than assumed away.
The rest: cystic, obstructive, toxic and unexplained
Polycystic kidney disease is the commonest inherited cause: cysts replace working tissue over decades, the kidneys become large rather than small, and hypertension appears early. There is no treatment that stops the cysts; the work is blood pressure, complication management, and planning ahead with a timeline that a family will recognise from its own history.
Obstruction is the cause most worth excluding, because it is one of the few where function can improve after treatment. Stones, an enlarged prostate, a narrowed junction between kidney and ureter, or a long-standing reflux problem all produce back-pressure that damages the kidney quietly and can be entirely silent until the damage is done. An ultrasound finds most of them, which is part of why it belongs in every initial assessment.
Drugs and toxins account for a smaller share of chronic disease and a much larger share of sudden deterioration. Non-steroidal anti-inflammatory painkillers are the commonest culprit; some antibiotics, contrast agents used in imaging, proton pump inhibitors taken for many years, and unregulated supplements or traditional preparations containing aristolochic acid or heavy metals appear in the list too. The practical rule is a list rather than a prohibition: know what is being taken, including what was bought without a prescription, and ask before starting anything new.
Gout and urate nephropathy deserve a mention because they run in both directions: raised urate damages the kidney, and reduced function raises urate further. It is one of the more satisfying loops to break.
And a substantial minority of patients — more when the disease is found late — never get a single cause. Small, scarred kidneys carry no fingerprint of the process that produced them. In that situation treatment is aimed at what remains measurable: pressure, protein leak, complications, and protection from further injury. That is not a lesser plan; it is the plan that applies to everyone, minus the one part that could have been targeted.
What accelerates the loss once it has begun
Beyond the cause, a short list of factors determines how fast function is lost — and most of them are addressable. This is the part of the disease patients have the most influence over.
| Accelerant | What it does | What can be done |
|---|---|---|
| Uncontrolled blood pressure | Damages the filtering vessels directly and drives the protein leak | Treat to an agreed target, with home readings rather than clinic snapshots |
| Ongoing protein leak | Protein crossing the filter is inflammatory to it | The medicines discussed on the treatment page, aimed at lowering pressure inside the filter |
| Nephrotoxic medicines | Add a second, superimposed injury | Review every medicine including over-the-counter ones; substitute where a safer option exists |
| Dehydration and acute illness | An episode of acute injury can cost years of function in a day or two | Plans for sick days, and asking which medicines to pause during vomiting or diarrhoea |
| Smoking | Accelerates the vascular damage and compounds cardiovascular risk | The single most valuable change available, at every stage |
| Salt and ultra-processed food | Raises pressure and fluid retention, and adds potassium and phosphate that an impaired kidney does not handle well | Dietetic advice tailored to the stage, since the targets change as function falls |